share_log

Alliance Global Partners Maintains Buy on Profound Medical, Raises Price Target to $15.75

Alliance Global Partners Maintains Buy on Profound Medical, Raises Price Target to $15.75

联盟全球合作伙伴维持对Profound Medical的买入,将目标股价上调至15.75美元
Benzinga ·  2023/05/11 06:48

Alliance Global Partners analyst Ben Haynor maintains Profound Medical (NASDAQ:PROF) with a Buy and raises the price target from $13.15 to $15.75.

Alliance Global Partners分析师本·海诺维持深远医疗(纳斯达克股票代码:PROF)的买入,并将目标股价从13.15美元上调至15.75美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发